Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure.

Felker, G M

Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure. [electronic resource] - American heart journal Dec 2001 - 932-3 p. digital

Publication Type: Comment; Comparative Study; Editorial

1097-6744

10.1067/mhj.2001.119611 doi


Adrenergic beta-Antagonists--adverse effects
Arrhythmias, Cardiac--chemically induced
Cardiotonic Agents--adverse effects
Clinical Trials as Topic
Cost-Benefit Analysis
Heart Failure--drug therapy
Heart Transplantation
Hemodynamics--drug effects
Humans
Hypotension--chemically induced
Research Design
Treatment Outcome